1. Home
  2. IMMP vs CTGO Comparison

IMMP vs CTGO Comparison

Compare IMMP & CTGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMMP
  • CTGO
  • Stock Information
  • Founded
  • IMMP 1987
  • CTGO 2009
  • Country
  • IMMP Australia
  • CTGO United States
  • Employees
  • IMMP N/A
  • CTGO N/A
  • Industry
  • IMMP Biotechnology: Pharmaceutical Preparations
  • CTGO Precious Metals
  • Sector
  • IMMP Health Care
  • CTGO Basic Materials
  • Exchange
  • IMMP Nasdaq
  • CTGO Nasdaq
  • Market Cap
  • IMMP 251.8M
  • CTGO 268.0M
  • IPO Year
  • IMMP N/A
  • CTGO N/A
  • Fundamental
  • Price
  • IMMP $1.97
  • CTGO $24.61
  • Analyst Decision
  • IMMP Buy
  • CTGO Strong Buy
  • Analyst Count
  • IMMP 1
  • CTGO 1
  • Target Price
  • IMMP $7.00
  • CTGO $37.00
  • AVG Volume (30 Days)
  • IMMP 120.6K
  • CTGO 180.0K
  • Earning Date
  • IMMP 10-10-2025
  • CTGO 11-13-2025
  • Dividend Yield
  • IMMP N/A
  • CTGO N/A
  • EPS Growth
  • IMMP N/A
  • CTGO N/A
  • EPS
  • IMMP N/A
  • CTGO N/A
  • Revenue
  • IMMP $3,306,742.00
  • CTGO N/A
  • Revenue This Year
  • IMMP $16.82
  • CTGO N/A
  • Revenue Next Year
  • IMMP N/A
  • CTGO N/A
  • P/E Ratio
  • IMMP N/A
  • CTGO N/A
  • Revenue Growth
  • IMMP 31.28
  • CTGO N/A
  • 52 Week Low
  • IMMP $1.32
  • CTGO $8.85
  • 52 Week High
  • IMMP $2.71
  • CTGO $26.28
  • Technical
  • Relative Strength Index (RSI)
  • IMMP 63.51
  • CTGO 56.40
  • Support Level
  • IMMP $1.75
  • CTGO $24.33
  • Resistance Level
  • IMMP $2.10
  • CTGO $25.75
  • Average True Range (ATR)
  • IMMP 0.09
  • CTGO 1.24
  • MACD
  • IMMP 0.03
  • CTGO -0.09
  • Stochastic Oscillator
  • IMMP 74.79
  • CTGO 57.23

About IMMP Immutep Limited

Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.

About CTGO Contango ORE Inc.

Contango Ore Inc operates in the United States. The company is engaged in the exploration of gold, silver, and copper ores in the State of Alaska. The company's focus is the exploration of a mineral lease with the Native Village of Tetlin whose governmental entity is the Tetlin Tribal Council for the exploration of minerals near Tok, Alaska. It has formed a joint venture to advance exploration of the Tetlin Property, which is prospective for gold and associated minerals. The Peak Gold JV Property is located in the Tetlin Hills and Mentasta Mountains of eastern interior Alaska. Its exploration projects are Lucky Shot, Johnson Tract, Eagle, Hona, Shamrock, and Triple Z.

Share on Social Networks: